Drug Shortage Report for AURO-ATORVASTATIN
Report ID | 77099 |
Drug Identification Number | 02407256 |
Brand name | AURO-ATORVASTATIN |
Common or Proper name | Atorvastatin |
Company Name | AURO PHARMA INC |
Market Status | MARKETED |
Active Ingredient(s) | ATORVASTATIN |
Strength(s) | 10MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 90 & 500 |
ATC code | C10AA |
ATC description | LIPID MODIFYING AGENTS, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2019-02-27 |
Estimated end date | |
Actual end date | 2019-03-07 |
Shortage status | Resolved |
Updated date | 2019-03-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3700 STEELES AVENUE WEST, SUITE 402 WOODBRIDGE, ONTARIO CANADA L4L 8K8 |
Company contact information | Anahita Rostami |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2019-03-08 | English | Compare |
v4 | 2019-03-07 | French | Compare |
v3 | 2019-03-07 | English | Compare |
v2 | 2019-02-28 | French | Compare |
v1 | 2019-02-28 | English | Compare |
Showing 1 to 5 of 5